Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /ERIS
chevron_leftBack

Eris Lifesciences Ltd.

ERIS
NSE: ERIS Delayed
1,474.20INR 5.4%
17.24 USD
As of 24 April 2025, Eris Lifesciences Ltd. has a market cap of $2.23B USD, ranking #4983 globally and #344 in India. It ranks #449 in the Healthcare sector, and #93 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
4983
Country Rank
344
Sector Rank
449
Industry Rank
93
Key Stats
Market Cap
$2.23BUSD
190.55B INR
Enterprise Value
$2.57BUSD
219.53B INR
Revenue (TTM)
$319.22MUSD
27.24B INR
EBITDA (TTM)
$98.24MUSD
8.4B INR
Net Income (TTM)
$38.6MUSD
3.29B INR
EBITDA Margin
31%
Profit Margin
12%
PE Ratio
57.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Amit Bakshi open_in_new
Employees
3,620
Founded
2007
Website
eris.co.in open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
5.4% 1.1% 0.6% 11% 5.4% 60%
Upcoming Earnings
Earnings Date
Fri, May 23

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
ERIS
Eris Lifesciences Ltd Registered Shs
ISIN: INE406M01024
Shares Out.:
136.163M1 Shares Float: 41.422M2
TV:
SA:
YF:
GF:
BA:
MS:
1.47K INR
Bombay Stock Exchange
MIC: XBOM
540596 (ERIS)
Eris Lifesciences Ltd Registered Shs
ISIN: INE406M01024
TV:
SA:
YF:
GF:
BA:
MS:
1.38K INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Eris Lifesciences Ltd.

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. It offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
2K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
724%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
548%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
492%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
459%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
3K%
Merck KGaA
MRK
$59.42B
52.43B EUR
3K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
2K%
Haleon plc
HLN
$45.57B
34.34B GBP
2K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
933%